Vral Anne, Decorte Veerle, Depuydt Julie, Wambersie André, Thierens Hubert
Department of Basic Medical Sciences, Ghent University, B‑9000 Ghent, Belgium.
Scientific Committee Centre de Services Interentreprises, External Service For Prevention and Protection at Work, B‑1200 Brussels, Belgium.
Mol Med Rep. 2016 Jul;14(1):103-10. doi: 10.3892/mmr.2016.5265. Epub 2016 May 13.
The aim of the present study was to perform cytogenetic analysis by means of a semi‑automated micronucleus‑centromere assay in lymphocytes from medical radiation workers. Two groups of workers receiving the highest occupational doses were selected: 10 nuclear medicine technicians and 10 interventional radiologists/cardiologists. Centromere‑negative micronucleus (MNCM‑) data, obtained from these two groups of medical radiation workers were compared with those obtained in matched controls. The blood samples of the matched controls were additionally used to construct a 'low‑dose' (0‑100 mGy) MNCM‑ dose‑response curve to evaluate the sensitivity and suitability of the micronucleus‑centromere assay as an 'effect' biomarker in medical surveillance programs. The physical dosimetry data of the 3 years preceding the blood sampling, based on single or double dosimetry practices, were collected for the interpretation of the micronucleus data. The in vitro radiation results showed that for small sized groups, semi‑automated scoring of MNCM‑ enables the detection of a dose of 50 mGy. The comparison of MNCM‑ yields in medical radiation workers and control individuals showed enhanced MNCM‑ scores in the medical radiation workers group (P=0.15). The highest MNCM‑ scores were obtained in the interventional radiologists/cardiologists group, and these scores were significantly higher compared with those obtained from the matched control group (P=0.05). The higher MNCM‑ scores observed in interventional radiologists/cardiologists compared with nuclear medicine technicians were not in agreement with the personal dosimetry records in both groups, which may point to the limitation of 'double dosimetry' procedures used in interventional radiology/cardiology. In conclusion, the data obtained in the present study supports the importance of cytogenetic analysis, in addition to physical dosimetry, as a routine biomonitoring method in medical radiation workers receiving the highest occupational radiation burdens.
本研究的目的是通过半自动微核着丝粒分析法对医学放射工作人员的淋巴细胞进行细胞遗传学分析。选取了接受最高职业剂量的两组工作人员:10名核医学技术人员和10名介入放射科医生/心脏病专家。将这两组医学放射工作人员的着丝粒阴性微核(MNCM-)数据与匹配对照组的数据进行比较。匹配对照组的血样还用于构建“低剂量”(0-100 mGy)MNCM-剂量反应曲线,以评估微核着丝粒分析法作为医学监测计划中“效应”生物标志物的敏感性和适用性。为了解释微核数据,收集了采血前3年基于单剂量或双剂量实践的物理剂量测定数据。体外辐射结果表明,对于小样本组,MNCM-的半自动评分能够检测到50 mGy的剂量。医学放射工作人员和对照个体的MNCM-产量比较显示,医学放射工作人员组的MNCM-评分有所提高(P=0.15)。介入放射科医生/心脏病专家组的MNCM-评分最高,与匹配对照组相比,这些评分显著更高(P=0.05)。介入放射科医生/心脏病专家的MNCM-评分高于核医学技术人员,这与两组的个人剂量测定记录不一致,这可能表明介入放射学/心脏病学中使用的“双剂量测定”程序存在局限性。总之,本研究获得的数据支持了细胞遗传学分析除物理剂量测定外,作为接受最高职业辐射负担的医学放射工作人员常规生物监测方法的重要性。